SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction

By sjmartinez • October 29, 2023

Avula V, Sharma G, Kosiborod MN, Vaduganathan M, Neilan TG, Lopez T, Dent S, Baldassarre L, Scherrer-Crosbie M, Barac A, Liu J, Deswal A, Khadke S, Yang EH, Ky B, Lenihan D, Nohria A, Dani SS, Ganatra S. SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction. JACC Heart Fail. 2023 Oct 12:S2213-1779(23)00596-6. doi: 10.1016/j.jchf.2023.08.026. Epub ahead of print. PMID: 37897456.

Tags: antineoplastic therapy, cardiomyopathy, Digestive Diseases, Outcomes, Publications, SGLT2 inhibitors

Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study

Asiimwe E, May F, Bendavid E. Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study.[...]

New Basic Science Editor and New Journal Management Committee Chair of Neurogastroenterology and Motility!

Corsetti M, Zerbib F, Black C, Shin A, Browning K, Keszthelyi D, Jones M. New Basic Science Editor and New Journal Management Committee Chair of[...]

Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta-Analysis

Maniyar I, Jajoo A, Brewer GG, Iyengar P, Nguyen A, Fasulo C, White J, Parian A, Limketkai BN. Dietary Sugar and Sweetened Beverage Intake Increases[...]